Actively Recruiting
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
Led by IRCCS Centro San Giovanni di Dio Fatebenefratelli · Updated on 2025-03-20
75
Participants Needed
1
Research Sites
77 weeks
Total Duration
On this page
Sponsors
I
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Lead Sponsor
U
University of Bologna
Collaborating Sponsor
AI-Summary
What this Trial Is About
Schizophrenia (SCZ) is a severe neuropsychiatric disorder characterized by cognitive decline, social withdrawal, and positive symptoms such as hallucinations and delusions. Research suggests that SCZ and schizotypy exist along a continuum, with shared structural and behavioral abnormalities, the latter of which encompass the sensory and perceptual domain, often in the form of altered multisensory integration, as seen in tasks like the Sound-Induced Flash Illusion (SIFI). Individuals with schizotypal traits or SCZ show enlarged temporal binding windows (TBW) of cross-modal integration, affecting perceptual accuracy and multisensory judgments. However, whether these deficits stem from overactive top-down modulation or weakened bottom-up sensory precision remains unclear. The current study seeks to address these questions, by asking participants (healthy individuals screened as for their schizotypal traits, and patients suffering from SCZ) to complete a modified version of the SIFI, as well as an audiovisual temporal order judgment (TOJ) task. Cross-modal performance will be assessed via signal detection theory (SDT) metrics and psychometric modeling to estimate individual TBWs, thereby assaying audiovisual processing abilities along the schizotypal continuum
CONDITIONS
Official Title
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Normal hearing
- Normal or corrected-to-normal vision
- Clinical diagnosis of schizophrenia spectrum disorder (according to DSM-5) for patients
- IQ greater than 70 for patients
You will not qualify if you...
- Any history or evidence of central nervous system alteration
- Current major physical illness for patients
- Drug dependency or abuse over the last 6 months for patients
- Unstable pharmacological therapy for patients
- Comorbidities with other major psychiatric disorders for patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, BS, Italy, 24125
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here